Avalyn Pharma Inc. (AVLN) IPO — S-1 Filing, Stock & Insider Activity

Avalyn Pharma Inc. IPO — Status & S-1 Filing

Ticker: AVLN
Status: Priced — IPO complete
S-1 filed: 2026-04-08
Effective: 2026-04-29
IPO / pricing date: 2026-04-30
Exchange: NASDAQ
Offering price: $18.00
Shares offered: 16,666,667
SEC CIK: 0001540171 · View the S-1 on SEC EDGAR →

Track every registration update on the InsiderAlpha IPO tracker.

Updated Jul 16, 2026 · Last SEC filing 2026-05-05

Avalyn Pharma Inc. (AVLN) has filed 14 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-05-05. 4 Form 8-K material event filings were reported by AVLN in the last 90 days. InsiderAlpha tracks every AVLN SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Avalyn Pharma Inc. (AVLN)

SEC CIK	0001540171

90-Day SEC Filing Activity

Form 4 filings (90d)	14
Form 8-K filings (90d)	4
Latest Form 4 filing	2026-05-05

Recent AVLN Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-05-01	Carroll Jill	Insider	J — Other acquisition / disposition	1.42M	—	—	SEC
2026-05-01	Carroll Jill	Insider	J — Other acquisition / disposition	489.5K	—	—	SEC
2026-05-01	Carroll Jill	Insider	P — Open-market purchase	277.8K	$18.00	$5.00M	SEC
2026-05-01	SR ONE CAPITAL MANAGEMENT, LLC	Insider	J — Other acquisition / disposition	1.42M	—	—	SEC
2026-05-01	SR ONE CAPITAL MANAGEMENT, LLC	Insider	J — Other acquisition / disposition	489.5K	—	—	SEC
2026-05-01	SR ONE CAPITAL MANAGEMENT, LLC	Insider	P — Open-market purchase	277.8K	$18.00	$5.00M	SEC
2026-05-01	SR ONE CAPITAL MANAGEMENT, LLC	Insider	J — Other acquisition / disposition	354.8K	—	—	SEC
2026-05-01	SR ONE CAPITAL MANAGEMENT, LLC	Insider	J — Other acquisition / disposition	489.5K	—	—	SEC
2026-05-01	SR ONE CAPITAL MANAGEMENT, LLC	Insider	P — Open-market purchase	277.8K	$18.00	$5.00M	SEC
2026-05-01	Wellington Biomedical Innovation Master Investors (Cayman) II L.P.	Insider	J — Other acquisition / disposition	1.28M	—	—	SEC
2026-05-01	FMR LLC	Insider	J — Other acquisition / disposition	727.6K	—	—	SEC
2026-05-01	FMR LLC	Insider	J — Other acquisition / disposition	80.3K	—	—	SEC
2026-05-01	FMR LLC	Insider	J — Other acquisition / disposition	872.9K	—	—	SEC
2026-05-01	FMR LLC	Insider	J — Other acquisition / disposition	225.8K	—	—	SEC
2026-05-01	FMR LLC	Insider	J — Other acquisition / disposition	377.9K	—	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Avalyn Pharma Inc. (AVLN). Updated in real time as new filings are submitted to the SEC.

Most-Active AVLN Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
SR ONE CAPITAL MANAGEMENT, LLC	10	$10.00M
FMR LLC	10	—
Novo Holdings A/S	7	$10.00M
Carroll Jill	5	$5.00M
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.	3	—

Recent AVLN Form 8-K Material Events

2026-07-01 — Item 1.01, 9.01 [SEC]
2026-06-17 — Item 7.01 [SEC]
2026-06-03 — Item 2.02, 9.01 [SEC]
2026-05-01 — Item 5.03, 9.01 [SEC]

Recent Insider Filings

2026-05-05 — Novo Holdings A/S (Insider)
2026-05-05 — FMR LLC (Insider)
2026-05-04 — Golden Adam H. (General Counsel)
2026-05-01 — Carroll Jill (Insider)
2026-05-01 — SR ONE CAPITAL MANAGEMENT, LLC (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in AVLN insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

AVLN Insider Trading — FAQ

What is the latest insider trade for AVLN?: Avalyn Pharma Inc. (AVLN) had 14 insider filings in the last 90 days, with the most recent on 2026-05-05. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying AVLN stock?: 0 insider purchases of AVLN were filed in the last 90 days.
How many insiders are selling AVLN stock?: 0 insider sales of AVLN were filed in the last 90 days.
Where can I see AVLN SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every AVLN SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live AVLN dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.